Blood News and Research

RSS

Midwest patient receives successful stem cell transplant to cure sickle cell disease

Chicagoan Ieshea Thomas is the first Midwest patient to receive a successful stem cell transplant to cure her sickle cell disease without chemotherapy in preparation for the transplant.

19 Jun 2012

Single-dose vaccine for treatment of cocaine addiction

A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel and groundbreaking strategy for treating cocaine addiction is described in an article published Instant Online in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc.

19 Jun 2012

Implanted device delivers genetically engineered neurotrophic factor directly to the brain

Studies suggest that neurotrophic factors, which play a role in the development and survival of neurons, have significant therapeutic and restorative potential for neurologic diseases such as Huntington's disease. However, clinical applications are limited because these proteins cannot easily cross the blood brain barrier, have a short half-life, and cause serious side effects.

19 Jun 2012

Delcath includes second-generation hemofiltration cartridge in chemosaturation system EAP

Delcath Systems, Inc. today announced that the Company has amended its Investigational New Drug (IND) application and its Expanded Access Program (EAP) to include the use of the second-generation hemofiltration cartridge of the Company's proprietary chemosaturation system.

19 Jun 2012

T2Endotoxin assay extends reach of T2MR detection

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on endotoxin detection at the American Society for Microbiology General Meeting, June 16-19, 2012, in San Francisco, CA.

18 Jun 2012

Humana, Novo Nordisk enter research partnership to explore diabetes treatment and care

Humana Inc. and Novo Nordisk Inc. today announced a one-year research partnership to explore diabetes treatment and care. Together, researchers will identify opportunities to change how patients might be treated to improve quality and outcomes for the millions of people who battle diabetes.

18 Jun 2012

Novel strategy for neutralizing unwanted molecules and clearing them from the body

Researchers have unveiled a novel strategy for neutralizing unwanted molecules and clearing them from the body.

18 Jun 2012

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

Two studies published back-to-back in last week's Nature applied DNA blood testing using the BEAMing technology to detect drug resistance mediated by KRAS mutations in colorectal cancer patients months before treatment failure was observed.

18 Jun 2012

FDA clears St. Jude Medical's AMPLATZER Vascular Plug 4 for transcatheter embolization

St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the AMPLATZER Vascular Plug 4 (AVP 4) for use in transcatheter embolization procedures (minimally invasive procedures that involve the selective blocking of blood vessels) within the peripheral vasculature.

18 Jun 2012

Penumbra adds MAX System of Reperfusion Catheters to family of aspiration thrombectomy devices

The Penumbra System family of aspiration thrombectomy devices now includes the MAX System of Reperfusion Catheters for removal of clots in patients experiencing acute ischemic stroke. The MAX System neuro-interventional devices offer a fast, simplified cerebral thrombectomy procedure with single-operator, over-the-wire delivery without the need for a large proximal balloon guide.

18 Jun 2012

Major advance in development of night-time automatic control device for blood glucose levels at home

Yet another exciting breakthrough took place yesterday in the advancement and development of the ARTIFICIAL PANCREAS by specialists at Schneider Children's Medical Center of Israel.

18 Jun 2012

CINJ commences enrollment in three-drug combination trial for breast cancer

Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.

18 Jun 2012

Is curry good for you?

There have been several news stories over the years reporting that curry may be good for us. Most of them refer to a chemical in curry, known as curcumin.

18 Jun 2012

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.

18 Jun 2012

ASH, EHA and ECPC issue common call to action to mitigate hematologic drug shortages

The American Society of Hematology (ASH) joined the European Hematology Association (EHA) and the European Cancer Patient Coalition (ECPC) today in issuing a common call to action in an effort to mitigate shortages of hematologic drugs in the United States and around the world.

18 Jun 2012

Ginger gum can cure migraine headaches

If you or someone you care about is among the one in 10 Americans who suffer with migraine headaches, recent research may provide some relief.

16 Jun 2012

Methodist receives $26.2M H&HS grant to reduce blood infections and delirium

Grants from the U.S. Department of Health & Human Services totaling $26.2 million will support work by The Methodist Hospital in Houston to reduce blood infections and delirium-caused injuries in Texas hospitals.

16 Jun 2012

Simple, inexpensive method for preventing type 2 diabetes

A simple, inexpensive method for preventing type 2 diabetes that relies on calling people and educating them on the sort of lifestyle changes they could make to avoid developing the disease has proven effective in a study conducted by researchers at the University of California, San Francisco (UCSF) and the City of Berkeley Department of Public Health.

16 Jun 2012

Urgent need for O Negative blood donations before the Olympics

New statistics from NHS Blood and Transplant (NHSBT) announced yesterday reveal a gap between demand and supply of blood type O Rh Negative (O Negative) during national celebrations and underline an urgent need for O Negative donors to come forward ahead of the Olympics next month.

16 Jun 2012

Not many EHR systems meet new federal standards

Electronic health records (EHRs) are used widely by California physicians, but many of their systems are not designed to meet new federal standards aimed at improving the quality of health care, according to a report from UCSF researchers.

16 Jun 2012

Blood News and Research

Midwest patient receives successful stem cell transplant to cure sickle cell disease

Single-dose vaccine for treatment of cocaine addiction

Implanted device delivers genetically engineered neurotrophic factor directly to the brain

Delcath includes second-generation hemofiltration cartridge in chemosaturation system EAP

T2Endotoxin assay extends reach of T2MR detection

Humana, Novo Nordisk enter research partnership to explore diabetes treatment and care

Novel strategy for neutralizing unwanted molecules and clearing them from the body

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

FDA clears St. Jude Medical's AMPLATZER Vascular Plug 4 for transcatheter embolization

Penumbra adds MAX System of Reperfusion Catheters to family of aspiration thrombectomy devices

Major advance in development of night-time automatic control device for blood glucose levels at home

CINJ commences enrollment in three-drug combination trial for breast cancer

Is curry good for you?

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

ASH, EHA and ECPC issue common call to action to mitigate hematologic drug shortages

Ginger gum can cure migraine headaches

Methodist receives $26.2M H&HS grant to reduce blood infections and delirium

Simple, inexpensive method for preventing type 2 diabetes

Urgent need for O Negative blood donations before the Olympics

Not many EHR systems meet new federal standards

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News